American Society of Hirudotherapy

The neurite-stimulating influence of components of medicinal leech salivary gland secretions in organotypic culture of spinal ganglia

Basic science published in Neurosci Behav Physiol (2003)

Last Updated: June 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Preclinical (animal)Salivary PharmacologyDrug DevelopmentChalisova NI et al. · Neuroscience and behavioral physiology, 2003

Abstract

The effects of components from medicinal leech (Hirudo medicinalis) salivary gland secretions and the therapeutic agent Piyavit on the growth of chick embryo neurites in organotypic culture were studied. Native destabilase and bdellin A at concentrations of 0.01, 0.02, 0.05, and 0.1 ng/ml, bdellin B at a concentration of 0.05 ng/ml, and eglin at a concentration of 0.1 ng/ml had neurite-stimulating activity, evident on the third day of organotypic culture of spinal ganglia. The stimulatory activity of destabilase was lost after revere-phase chromatography. The neurite-stimulating activity of the extract of the therapeutic agent Piyavit (200 ng/ml) in organotypic ganglion culture appeared to result from the neurite-stimulating salivary gland components within this agent, suggesting that Piyavit could be used for the treatment of neurodegenerative disorders.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeComparative StudyJournal ArticleResearch Support, Non-U.S. Gov't
Indexed MeSH termsAnimalsBiological FactorsChick EmbryoDose-Response Relationship, DrugEndopeptidasesFibrinolytic AgentsGanglia, SpinalLeechesNeuritesOrgan Culture TechniquesOrganic ChemicalsProtease InhibitorsProteinsSalivary GlandsSerpins

Summary

In organotypic chick embryo spinal ganglia cultures, destabilase and bdellin A at 0.01-0.1 ng/ml, bdellin B at 0.05 ng/ml, and eglin at 0.1 ng/ml each showed neurite-stimulating activity on day three.

Why This Matters for Hirudotherapy

This study examined the effects of individual Hirudo medicinalis salivary gland secretion components—destabilase, bdellin A, bdellin B, and eglin—as well as the therapeutic agent Piyavit, on neurite growth in organotypic cultures of chick embryo spinal ganglia. Several components showed neurite-stimulating activity at very low concentrations (0.01–0.1 ng/ml), and Piyavit's activity at 200 ng/ml was attributed to its salivary gland components, suggesting potential use in neurodegenerative disorders. The study identifies specific leech secretome proteins with neurotrophic properties. However, this is a preclinical organotypic culture study using chick embryo tissue; no in vivo or clinical data are presented, and the neurodegenerative disease suggestion remains speculative and untested.

Citation

Reference (Vancouver style)

Chalisova NI, Baskova IP, Zavalova LL, Pennijainen VA. The neurite-stimulating influence of components of medicinal leech salivary gland secretions in organotypic culture of spinal ganglia. Neurosci Behav Physiol. 2003;33(1):85-88. doi:10.1023/a:1021187500632. PMID: 12617308

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

DOIPubMed

Added to ASH library: May 27, 2026 · Site last updated: June 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.